Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Dyslipidemia

  Free Subscription


08.01.2018

2 AIDS
3 PLoS One
1 Postgrad Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. TORIBIO M, Fitch KV, Sanchez L, Burdo TH, et al
    Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in intrepid: a randomized trial in HIV.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001427.
    PubMed     Text format     Abstract available

  2. JOSHI PH, Miller PE, Martin SS, Jones SR, et al
    Greater remnant lipoprotein cholesterol reduction with pitavastatin compared to pravastatin in HIV-infected patients: The INTREPID trial.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001423.
    PubMed     Text format     Abstract available


    PLoS One

  3. RIMPEEKOOL W, Yiengprugsawan V, Kirk M, Banwell C, et al
    Nutrition label experience, obesity, high blood pressure, and high blood lipids in a cohort of 42,750 Thai adults.
    PLoS One. 2017;12:e0189574.
    PubMed     Text format     Abstract available

  4. SHU H, Chi J, Li J, Zhang W, et al
    A novel indel variant in LDLR responsible for familial hypercholesterolemia in a Chinese family.
    PLoS One. 2017;12:e0189316.
    PubMed     Text format     Abstract available

  5. COSTABILE A, Buttarazzi I, Kolida S, Quercia S, et al
    An in vivo assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults.
    PLoS One. 2017;12:e0187964.
    PubMed     Text format     Abstract available


    Postgrad Med

  6. ZHOU J, Zhang Q, Wang Y, Gao P, et al
    The effect and safety of anacetrapib in the treatment of dyslipidemia: a systematic review and meta-analysis.
    Postgrad Med. 2018;130:129-136.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: